Dorothy Meets Up with the ‘Fella Brick Road’
The Janssen Pharmaceutical story may seem like a ‘Fairy Tale’ to some, but for many it was a nightmare. So far in this case study, it’s been ‘Follow the Fella Brick Road’
Until we complete the ‘Trifecta of Terrific’ with:
Alex and Gary
Johnson & Johnson Janssen Pharmaceutica Inc.
1999-2003 Business Unit Leader, Janssen-Ortho., Janssen, Pharmaceutical Companies of Johnson & Johnson
2003-2005 Executive Director, Global Marketing Leader, Janssen, Pharmaceutical Companies of Johnson & Johnson
2005-2008 VP of Sales & Marketing, Janssen, Pharmaceutical Companies of Johnson & Johnson
2009-2010 VP of Commercial Analytics Operations, Janssen, Pharmaceutical Companies of Johnson & Johnson
2010-2011 Worldwide President, Ethicon Women’s Health & Urology (Ethicon is a Division of Johnson & Johnson (Anyone curious about this Company?)
2011-2013 Worldwide President at Acclarent a Johnson & Johnson Company (How about this Company?)
It appears that Bridget does not have a bio on the official company website, like Alex and Gary…and maybe that’s why she still has all of her history on her LinkedIn page.
And now we have the players for the case study over the next few months. Tomorrow, the timeline as it relates the ‘Trifecta of Terrific,’ and the qui tam (whistleblower) lawsuit over Risperdal, which started in April 2004 and was finalized in 2012, with Johnson & Johnson’s Janssen Pharmaceutical paying the Department of Justice $2.2 billion.